{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:34:49Z","timestamp":1793237689336,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:00Z","timestamp":1782950400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000125","name":"National Institute for Occupational Safety and Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000125","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008616","name":"Rush University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008616","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jacadv.2026.103071","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T06:02:56Z","timestamp":1785218576000},"page":"103071","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perfluoroalkyl\/Polyfluoroalkyl Substances, Hemostatic\/Inflammatory Biomarkers, and Incident Hypertension"],"prefix":"10.1016","volume":"5","author":[{"given":"Yundan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1877-1064","authenticated-orcid":false,"given":"Wenzhiyuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carrie A.","family":"Karvonen-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia M.","family":"Calafat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Herman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhramar","family":"Mukherjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9981-6250","authenticated-orcid":false,"given":"Sung Kyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacadv.2026.103071_bib1","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12302-023-00721-8","article-title":"PFAS: forever chemicals\u2014persistent, bioaccumulative and mobile. Reviewing the status and the need for their phase out and remediation of contaminated sites","volume":"35","author":"Brunn","year":"2023","journal-title":"Environ Sci Eur"},{"key":"10.1016\/j.jacadv.2026.103071_bib2","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.envint.2013.06.004","article-title":"Accumulation of perfluoroalkyl substances in human tissues","volume":"59","author":"Perez","year":"2013","journal-title":"Env Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2024.134556","article-title":"Per- and polyfluoroalkyl substances and human health outcomes: an umbrella review of systematic reviews with meta-analyses of observational studies","volume":"472","author":"Xing","year":"2024","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jacadv.2026.103071_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2020.110361","article-title":"Association between per and polyfluoroalkyl substances and markers of inflammation and oxidative stress","volume":"196","author":"Omoike","year":"2021","journal-title":"Env Res"},{"key":"10.1016\/j.jacadv.2026.103071_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106853","article-title":"Prenatal and postnatal exposure to PFAS and cardiometabolic factors and inflammation status in children from six European cohorts","volume":"157","author":"Papadopoulou","year":"2021","journal-title":"Env Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib7","doi-asserted-by":"crossref","first-page":"13419","DOI":"10.1021\/acs.est.3c04688","article-title":"Association between a mixture of Per- and Polyfluoroalkyl Substances (PFAS) and inflammatory biomarkers in the Atlanta African American maternal-child cohort","volume":"57","author":"Tan","year":"2023","journal-title":"Env Sci Technol"},{"key":"10.1016\/j.jacadv.2026.103071_bib8","series-title":"StatPearls Publishing","article-title":"C reactive protein: clinical relevance and interpretation","author":"Nehring","year":"2025"},{"key":"10.1016\/j.jacadv.2026.103071_bib9","article-title":"Fibrinolysis: an illustrated review","volume":"7","author":"Risman","year":"2023","journal-title":"Res Pr Thromb Haemost"},{"issue":"Suppl C","key":"10.1016\/j.jacadv.2026.103071_bib10","first-page":"C39","article-title":"Haemostatic risk factors for cardiovascular diseases","volume":"19","author":"Koenig","year":"1998","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacadv.2026.103071_bib11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1378\/chest.110.3.710","article-title":"Coagulation and fibrinolytic profiles in patients with severe pulmonary hypertension","volume":"110","author":"Welsh","year":"1996","journal-title":"Chest"},{"key":"10.1016\/j.jacadv.2026.103071_bib12","doi-asserted-by":"crossref","first-page":"49","DOI":"10.11613\/BM.2012.006","article-title":"Inflammation and haemostasis","volume":"22","author":"Margetic","year":"2012","journal-title":"Biochem Med Zagreb"},{"key":"10.1016\/j.jacadv.2026.103071_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2025.138189","article-title":"Perfluoroalkyl and polyfluoroalkyl substances crossing the blood-joint barrier: their occurrence and distribution in synovial fluid","volume":"492","author":"Guo","year":"2025","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.jacadv.2026.103071_bib14","article-title":"Association of per- and polyfluoroalkyl substance exposure with fatty liver disease risk in US adults","volume":"5","author":"Zhang","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jacadv.2026.103071_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2024.118434","article-title":"Associations of per- and polyfluoroalkyl substances with maternal metabolic and inflammatory biomarkers in early-to-mid-pregnancy","volume":"250","author":"Cinzori","year":"2024","journal-title":"Environ Res"},{"key":"10.1016\/j.jacadv.2026.103071_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2024.109145","article-title":"Prenatal exposure to per- and polyfluoroalkyl substances (PFAS) and their influence on inflammatory biomarkers in pregnancy: findings from the LIFECODES cohort","volume":"194","author":"Siwakoti","year":"2024","journal-title":"Environ Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib17","doi-asserted-by":"crossref","DOI":"10.1289\/EHP1062","article-title":"Exposure to perfluoroalkyl substances and metabolic outcomes in pregnant women: evidence from the Spanish INMA birth cohorts","volume":"125","author":"Matilla-Santander","year":"2017","journal-title":"Env Health Perspect"},{"key":"10.1016\/j.jacadv.2026.103071_bib18","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3390\/ijms21020399","article-title":"Increased cardiovascular risk associated with chemical sensitivity to perfluoro-octanoic acid: role of impaired platelet aggregation","volume":"21","author":"De Toni","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jacadv.2026.103071_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106584","article-title":"Interference of C6O4 on platelet aggregation pathways: cues on the new-generation of perfluoro-alkyl substance","volume":"154","author":"Minuz","year":"2021","journal-title":"Env Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib20","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1161\/HYPERTENSIONAHA.121.18809","article-title":"Per- and polyfluoroalkyl substances and incident hypertension in multi-Racial\/Ethnic women: the study of women\u2019s health across the nation","volume":"79","author":"Ding","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/j.jacadv.2026.103071_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2025.122765","article-title":"Exposure to high levels of perfluoroalkyl substances through drinking water and risk of cardiovascular morbidity and mortality in a Swedish register-based study","volume":"286","author":"Zhou","year":"2025","journal-title":"Environ Res"},{"key":"10.1016\/j.jacadv.2026.103071_bib22","first-page":"108","article-title":"Per- and polyfluoroalkyl substances, apolipoproteins and the risk of coronary heart disease in US men and women","volume":"23","author":"Zhu","year":"2024","journal-title":"Environ Health Glob Access Sci Source"},{"key":"10.1016\/j.jacadv.2026.103071_bib23","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1055\/s-0030-1262902","article-title":"Metabolic implications of menopause","volume":"28","author":"Polotsky","year":"2010","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.jacadv.2026.103071_bib24","series-title":"Biology and Pathobiology","first-page":"175","article-title":"SWAN a multi-center, multi-ethnic, community-based cohort study of women and the menopausal transition","author":"Sowers","year":"2000"},{"key":"10.1016\/j.jacadv.2026.103071_bib25","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.chroma.2010.10.051","article-title":"Improved selectivity for the analysis of maternal serum and cord serum for polyfluoroalkyl chemicals","volume":"1218","author":"Kato","year":"2011","journal-title":"J Chromatogr A"},{"key":"10.1016\/j.jacadv.2026.103071_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105381","article-title":"Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: the study of Women\u2019s health across the nation","volume":"135","author":"Ding","year":"2020","journal-title":"Env Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib27","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.envres.2019.05.028","article-title":"Determinants of per- and polyfluoroalkyl substances (PFAS) in midlife women: evidence of racial\/ethnic and geographic differences in PFAS exposure","volume":"175","author":"Park","year":"2019","journal-title":"Env Res"},{"key":"10.1016\/j.jacadv.2026.103071_bib28","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaf175","article-title":"The relation between systemic inflammation and the menopause transition: the study of women\u2019s health across the nation","volume":"110","author":"El Khoudary","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacadv.2026.103071_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/5459a88b-e488-4d4c-bd59-e7e8e99c8867","article-title":"Gender, obesity and repeated elevation of C-reactive protein: data from the CARDIA cohort","volume":"7","author":"Ishii","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jacadv.2026.103071_bib30","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.exger.2013.10.016","article-title":"Prospective associations between inflammatory and hemostatic markers and physical functioning limitations in mid-life women: longitudinal results of the Study of Women\u2019s Health across the Nation (SWAN)","volume":"49","author":"McClure","year":"2014","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.jacadv.2026.103071_bib31","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on prevention, detection, evaluation, and treatment of high blood PressureThe JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.jacadv.2026.103071_bib32","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1038\/s41366-021-00848-9","article-title":"Perfluoroalkyl and polyfluoroalkyl substances and body size and composition trajectories in midlife women: the study of women\u2019s health across the nation 1999-2018","volume":"45","author":"Ding","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/j.jacadv.2026.103071_bib33","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/oxfordjournals.aje.a114416","article-title":"A data-based approach to diet questionnaire design and testing","volume":"124","author":"Block","year":"1986","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jacadv.2026.103071_bib34","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/pmed.1998.0470","article-title":"Physical activity patterns in a diverse population of women","volume":"28","author":"Sternfeld","year":"1999","journal-title":"Prev Med"},{"key":"10.1016\/j.jacadv.2026.103071_bib35","doi-asserted-by":"crossref","DOI":"10.1289\/EHP5838","article-title":"A quantile-based g-Computation approach to addressing the effects of exposure mixtures","volume":"128","author":"Keil","year":"2020","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jacadv.2026.103071_bib36","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/EDE.0b013e31821db37e","article-title":"Causal mediation analysis with survival data","volume":"22","author":"VanderWeele","year":"2011","journal-title":"Epidemiology"},{"key":"10.1016\/j.jacadv.2026.103071_bib37","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1289\/ehp.6316","article-title":"Perfluorooctanesulfonate and other fluorochemicals in the serum of American red cross adult blood donors","volume":"111","author":"Olsen","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.jacadv.2026.103071_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104699","article-title":"Exposures to perfluoroalkyl substances and asthma phenotypes in childhood: an investigation of the COPSAC2010 cohort","volume":"94","author":"Sevelsted","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/j.jacadv.2026.103071_bib39","doi-asserted-by":"crossref","first-page":"89081","DOI":"10.1007\/s11356-022-22021-z","article-title":"Association of increased risk of cardiovascular diseases with higher levels of perfluoroalkylated substances in the serum of adults","volume":"29","author":"Feng","year":"2022","journal-title":"Env Sci Pollut Res Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2020.622473","article-title":"Targeting PAI-1 in cardiovascular disease: structural insights into PAI-1 functionality and inhibition","volume":"7","author":"Sillen","year":"2020","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacadv.2026.103071_bib41","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1097\/CCM.0b013e3181c9cbd9","article-title":"Thrombotic risk factors: basic pathophysiology","volume":"38","author":"Martinelli","year":"2010","journal-title":"Crit Care Med"},{"key":"10.1016\/j.jacadv.2026.103071_bib42","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1213\/ane.0b013e31819bceb1","article-title":"The role of tissue factor and factor VIIa in hemostasis","volume":"108","author":"Mackman","year":"2009","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jacadv.2026.103071_bib43","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/sj.jhh.1001051","article-title":"Hypertension and the prothrombotic state","volume":"14","author":"Lip","year":"2000","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.jacadv.2026.103071_bib44","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1055\/s-0031-1297367","article-title":"Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective","volume":"37","author":"Lijfering","year":"2011","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jacadv.2026.103071_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.115188","article-title":"A systematic evidence map of chronic inflammation and immunosuppression related to per- and polyfluoroalkyl substance (PFAS) exposure","volume":"220","author":"Zhang","year":"2023","journal-title":"Environ Res"},{"key":"10.1016\/j.jacadv.2026.103071_bib46","doi-asserted-by":"crossref","DOI":"10.1289\/EHP12351","article-title":"Per- and Polyfluoroalkyl Substances (PFAS) and lipid trajectories in women 45-56 years of age: the study of women\u2019s health across the nation","volume":"131","author":"Kang","year":"2023","journal-title":"Env Health Perspect"},{"key":"10.1016\/j.jacadv.2026.103071_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijheh.2021.113777","article-title":"Associations of perfluoroalkyl and polyfluoroalkyl substances (PFAS) and PFAS mixtures with adipokines in midlife women","volume":"235","author":"Ding","year":"2021","journal-title":"Int J Hyg Env Health"},{"key":"10.1016\/j.jacadv.2026.103071_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2023.115813","article-title":"The role of exposure to per- and polyfluoroalkyl substances in racial\/ethnic disparities in hypertension: results from the study of Women\u2019s health across the nation","volume":"227","author":"Ding","year":"2023","journal-title":"Env Res"},{"key":"10.1016\/j.jacadv.2026.103071_bib49","series-title":"Toxicological profile for Perfluoroalkyls","year":"2021"},{"key":"10.1016\/j.jacadv.2026.103071_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.105381","article-title":"Longitudinal trends in perfluoroalkyl and polyfluoroalkyl substances among multiethnic midlife women from 1999 to 2011: the Study of Women's Health across the nation","volume":"135","author":"Ding","year":"2020","journal-title":"Environ Int"},{"key":"10.1016\/j.jacadv.2026.103071_bib51","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12940-020-00588-9","article-title":"Associations between perfluoroalkyl substances and serum lipids in a Swedish adult population with contaminated drinking water","volume":"19","author":"Li","year":"2020","journal-title":"Environ Health"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103071_bib52","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1289\/EHP273","article-title":"A Study of reverse causation: examining the associations of perfluorooctanoic acid serum levels with two outcomes","volume":"125","author":"Dhingra","year":"2017","journal-title":"Environ Health Perspect"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T01:28:08Z","timestamp":1793237288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26004928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":51,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2772963X26004928"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103071","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perfluoroalkyl\/Polyfluoroalkyl Substances, Hemostatic\/Inflammatory Biomarkers, and Incident Hypertension","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103071"}}